Endocrinologists’ $10k fees from industry raise concerns over conflict of interest

Undisclosed pharmaceutical industry ties are common among endocrinologist ‘key opinion leaders’ who hold leadership positions in diabetes organisations, an Australian study has found. Industry fees averaging $10,702 (range $2638–$28,744) were made to 24 of 33 endocrinologists who held positions with professional medical groups between 205 and 2018, according to an analysis by Sydney University researchers. ...

Already a member?

Login to keep reading.

© 2021 the limbic